SITESEEKER screening platform.
More about PhoreMost
PhoreMost Ltd is a UK-based biopharmaceutical company dedicated to drug discovery and development. Founded in 2014 and based in Cambridge, the company aims to "Drug the Undruggable®" by creating more effective and affordable targeted medicines for patients. PhoreMost was established as a spin-out from the University of Cambridge's MRC Cancer Unit and is co-founded by Dr. Chris Torrance and academic partners. The company utilizes its proprietary technology, PROTEINi®, as the foundation for its SITESEEKER® platform. This next-generation phenotypic screening platform identifies novel drug targets and links them to therapeutic functions in live cells. PhoreMost also offers GlueSEEKER™, which focuses on discovering molecular glue degraders for targeted protein degradation. The company primarily targets oncology and targeted protein degradation in its drug development efforts and collaborates with various industry partners to advance its pipeline. With around 40 employees, PhoreMost is actively engaged in pharmaceutical product development and has secured significant funding to support its initiatives.
Live roles
Alert me when PhoreMost posts a new role Email me when this changes
Similar Cambridge companies
Full directory →- AstraZeneca 13 live
Cambridge-headquartered global pharma; major presence at the Cambridge Biomedical Campus. Heavy AI/ML hiring across genetics, drug discovery and biologics engineering.
- GSK 6 live
Global pharma; Stevenage R&D campus is the company's largest UK research site. Active in AI/ML for drug discovery, translational data, and oncology pharmacology.
- biomodal (Cambridge Epigenetix)
Cambridge-area genomics company (formerly Cambridge Epigenetix) building multiomics DNA-sequencing technology and bioinformatics.
- Cancer Research Horizons / CRUK Cambridge Institute
Research institute; substantial computational teams.
- CardiaTec Biosciences
Multiomics + AI.
- Genomics plc
Cambridge office (careers page).